Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics - a podcast by Synthego

In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. 

Further episodes of CRISPR Cuts

Further podcasts by Synthego

Website of Synthego